Multimodal Prehabilitation for Resectable Gastric Cancer
Stomach Neoplasm
About this trial
This is an interventional treatment trial for Stomach Neoplasm focused on measuring Gastric cancer
Eligibility Criteria
Inclusion Criteria: Pathologically confirmed gastric cancer, clinical I-III TNM stage (AJCC 8th edition); Will receive curative-intent surgery; Life expectance > 6 months; Exclusion Criteria: Gastric stump cancer or combined with other malignances; NYHA III, NYHA IV; Inability to swallow, with gastrostomy, or inability to move because of orthopedic disease or neuromuscular disease; Psychiatric disorders, COPD, end-stage hepatic or renal disease, uncontrolled cardiac arhythmia or uncontrolled hypertention; Receiving immunosuppressive therapy; Emergency surgery because of tumor bleeding or tumor perforation;
Sites / Locations
- Chinese PLA General Hospital First Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Prehabilitation arm
Control arm
Patient receives prehabilitation intervention including exercise, nutrition and psychological support.
Patient receives regular care recommended by the WHO without supervision and support.